Knockdown of LRPPRC in ovarian cancer cells is believed to impact the assembly of complex IV by decreasing SCO1, while simultaneously affecting the biosynthesis of complex IV through the downregulation of FDX1 and lipoic acidylated proteins. Here, LRPPRC is linked to ovarian carcinoma.